GXDX Genoptix, Inc. (MM)

CARLSBAD, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Genoptix, Inc. (NASDAQ:GXDX), a specialized laboratory services provider, today announced the Company's participation at the UBS Global Life Sciences Conference scheduled to take place at the Grand Hyatt in New York City on September 22 - 25, 2008. Douglas Schuling, Senior Vice President and CFO of Genoptix, will present at the conference on Monday, September 22, beginning at approximately 3:30 pm EDT. Mr. Schuling will provide an overview of the Company's specialized diagnostic laboratory service offerings, growth strategies and past operational performance. The presentation is expected to last approximately 30 minutes, followed by a 30 minute break-out session. The presentation will be web cast live and made accessible through the investor relations section of the Genoptix website at http://www.genoptix.com/. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast. About Genoptix, Inc. Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community- based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California. Forward-Looking Statements This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements. DATASOURCE: Genoptix, Inc. CONTACT: Marcy Graham, Sr. Director, Investor Relations, of Genoptix, Inc., +1-760-930-7150, ; or Joleen Schultz, Principal of Mentus, +1-858-455-5500 ext 215, , for Genoptix, Inc. Web site: http://www.genoptix.com/

Copyright